Why the study?
Diabetes increases the risk of severe SARS-Cov-2 infection, and severe SARS-Cov-2 infection itself may worsen outcomes in diabetes through acute metabolic complications, motivating a systematic assessment of their mutual effects and prognostic factors.
Answers are grounded in this paper and cite their sources.
Highlights the bidirectional relationship between SARS-CoV-2 infection and metabolic conditions like diabetes and obesity.
Since the first outbreak of SARS-Cov-2 in China, much attention has been paid by the medical community to people with diabetes, as it is well known that diabetes increases the risk of developing various infectious diseases. The reason for this is multifactorial: age, gender, ethnicity, concomitant diseases such as hypertension and cardiovascular diseases, obesity, as well as pro-inflammatory and procoagulatory conditions – all these factors contribute to a more severe course of SARS-Cov-2 in patients with diabetes mellitus. Moreover, severe SARS-Cov-2 infection itself may be a worsening factor for people with diabetes, as it can cause acute metabolic complications through direct negative effects on beta-cell function. This review is intended to provide a systematic assessment of potential prognostic factors and mutual effects in patients with diabetes mellitus, obesity and SARS-Cov-2.
No takes yet. Share an insight, caveat, or question.
Никонова et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: